Real-world data is everywhere. During the COVID-19 global pandemic, we are literally generating, and collecting, real-world data every single day—from electronic health records, insurance claims, patient registries, and a myriad of other sources. But the question remains: how do we use this data to better understand, prevent, and treat this disease?
Early in the War Against Cancer, when huge amounts of federal funds were suddenly funneled into cancer research, many scientists and clinicians working in other fields suddenly found it convenient—if not essential—to incorporate cancer into the title of their grant applications.
As we approach the middle of June, Georgia appears to have come to the other side of its COVID-19 curve. Available information from the Georgia Department of Health reveals Georgia has nearly 54,000 confirmed COVID-19 cases, with the heaviest concentration of cases in the metro Atlanta area (as a result of population size, not density).
Since the dawn of man: when a novel virus is introduced to the human species, the world is changed forever. Despite all of our advances—we can share information around the globe in seconds and we can fly to the moon—a never-before-seen virus can stop us all in our tracks and steal people’s lives too soon.
The year 2020 will no doubt be recorded as one of the most tumultuous in our nation’s, if not the world’s, history.
“Please welcome Claudia to the stage; she will be discussing resistance mechanisms to immune checkpoint inhibitors.”
The past ten days have seen an outpouring of emotions as American society, devastated by the tragic murder of George Floyd by four Minneapolis police officers, plunges into a crisis of conscience.
I am almost certain that no other director of an NCI-designated cancer center can claim the distinction of having had a gun pulled on them by police.
Nicole Kuderer and colleagues are to be congratulated for their report—in The Lancet and at the ASCO 2020 Annual Meeting—on the impact of COVID-19 on a cohort of patients with cancer.
As the healthcare system faces the onslaught of the novel coronavirus SARS-CoV-2, clinicians caring for individuals with cancer face the challenge of a wide gap in knowledge needed to guide decision-making.
